Physician profile
David Meir-Levi
NPI 1053311795
$569.04
in general payments reported to CMS, 2019-2025
12 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.15 · 2020: $79.78 · 2021: $51.56 · 2022: $104 · 2023: $85.18 · 2024: $61.61 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $262.61 | 2021-2025 | Endurant Iis |
| Smith+Nephew, INC. | $65.81 | 2019-2025 | Collagenase Santyl |
| Endologix LLC | $61.61 | 2024 | Endocross Device, Torus Stent Graft System |
| Baxter Healthcare | $33.49 | 2023 | Preveleak |
| Hydrofera LLC | $25.63 | 2021 | |
| Medline Industries LP | $23.41 | 2020 | |
| Cook Medical LLC | $22.16 | 2023 | Zilver Vena |
| Lemaitre Vascular, INC. | $16.39 | 2023 | Restoreflow |
| Kci USA, INC. | $14.82 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.69 | 2020 | |
| Bard Peripheral Vascular, INC. | $14.42 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Meir-Levi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.